Macrophage-specific lipid nanoparticle therapy blocks the lungs mechanosensitive immunity due to macrophage-epithelial interactions

Liberty Mthunzi,Mohammad N Islam,Galina A Gusarova,Sunita Bhattacharya,Brian Karolewski,Jahar Bhattacharya
DOI: https://doi.org/10.1101/2023.05.24.541735
2024-10-26
Abstract:The mechanistic basis of ventilator-induced lung injury (VILI), which exacerbates morbidity in the acute respiratory distress syndrome (ARDS), remains unclear. We evaluated the current understanding that alveolar overexpansion during ventilator therapy stretches alveolar macrophages (AMs), initiating injurious immune signaling. However, live confocal imaging of mouse and human lungs revealed that although hyperinflation caused alveolar expansion, AMs failed to stretch. Surprisingly however, calcium increases occurred in a subset of the AMs. Mechanistic studies in mice involving AM-specific knockout of the gap junctional gene, Connexin 43 (Cx43), revealed that the hyperinflation-induced AM responses were attributable to AM-epithelium gap junctional communication (GJC). The AM responses, as also lung injury due to mechanical ventilation at high tidal volume (HTV), were inhibited by the Cx43 knockout, and by AM-specific delivery of lipid nanoparticles containing Xestospongin C (LNP-XeC), which blocks Ca2+ release from intracellular stores. We conclude, Cx43 dependent GJC, and not AM stretch determines the lungs AM-induced mechanosensitive immunity. LNP-XeC delivery provides a potential strategy for precision therapy against mechanosensitive AM responses underlying VILI.
Physiology
What problem does this paper attempt to address?